Interpretation: Valid Test Showing Appropriate HPA Axis Suppression
These results indicate a valid dexamethasone suppression test with appropriate suppression of the hypothalamic-pituitary-adrenal (HPA) axis, effectively ruling out endogenous Cushing's syndrome. The high dexamethasone level (327 ng/mL) confirms adequate drug absorption and compliance, while the suppressed cortisol (1.1 μg/dL or ~30 nmol/L) and undetectable ACTH (<5 pg/mL) demonstrate normal negative feedback 1, 2.
Why This Test is Valid
The dexamethasone level of 327 ng/mL (approximately 8.4 nmol/L) is well above the minimum threshold needed for valid interpretation:
- Adequate dexamethasone concentration confirmed: Research demonstrates that dexamethasone levels ≥0.1 μg/dL (≥2.8 nmol/L) are sufficient for valid test interpretation, with 97.6% of normal subjects achieving this level 3
- Your patient's level is roughly 30-fold higher than the minimum threshold, eliminating any concern about inadequate drug absorption or non-compliance 4
Interpretation of Each Component
Cortisol 1.1 μg/dL (30 nmol/L):
- This is well below the diagnostic threshold of 1.8 μg/dL (50 nmol/L) used to exclude Cushing's syndrome 1, 5
- Normal suppression effectively rules out autonomous cortisol production
- Even patients with mild autonomous cortisol secretion typically fail to suppress below 1.8 μg/dL 6
ACTH <5 pg/mL:
- Appropriately suppressed in response to dexamethasone administration
- Confirms intact negative feedback at the pituitary level
- This degree of ACTH suppression (ACTH ratio likely <18% of baseline) further validates the test result 6
Dexamethasone level 327 ng/mL:
- Eliminates false-negative results from poor absorption, drug interactions, or non-compliance
- Studies show that measuring dexamethasone levels reduces false-positive rates by identifying subtherapeutic levels, but your patient clearly has therapeutic levels 3, 4
Clinical Implications
No further endocrine testing is needed if this test was performed to screen for Cushing's syndrome. The combination of:
- Therapeutic dexamethasone level
- Suppressed cortisol (<1.8 μg/dL)
- Suppressed ACTH
...provides definitive evidence against endogenous hypercortisolism 1, 5.
Important Caveats
If the patient has been on chronic glucocorticoid therapy, these results instead indicate glucocorticoid-induced adrenal insufficiency:
- The suppressed ACTH and low cortisol despite adequate dexamethasone exposure suggest HPA axis suppression from prior glucocorticoid use
- Recovery requires morning cortisol >300 nmol/L (>10 μg/dL) off all glucocorticoids 2
- Continue physiologic glucocorticoid replacement and recheck morning cortisol every few weeks until recovery occurs 2
Factors that do NOT apply here (but are worth knowing):
- Oral contraceptive use can cause false-positive DST results due to elevated cortisol-binding globulin, but this patient's cortisol is appropriately suppressed 3
- Drug interactions with phenytoin, phenobarbital, rifampin can lower dexamethasone levels, but this patient has therapeutic levels 7
- Indomethacin can cause false-negative DST results, but again, this patient's high dexamethasone level confirms adequate drug exposure 7
Bottom Line
This is a normal dexamethasone suppression test that excludes Cushing's syndrome. The high dexamethasone level validates the test result and eliminates concerns about drug absorption or compliance. No additional biochemical testing for hypercortisolism is warranted based on these results 1, 5.